The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL
Status:
Terminated
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the treatment of Alemtuzumab in combination
with CHOP(cyclophosphamide,doxorubicin,vincristine and prednisolone) are effective as first
line treatment in patients with peripheral T-cell lymphoma.